By Kathrin Folkendt Hormonal Health, News, Pharma, Reproductive Health January 31, 2024 ShareTwitterFacebookPinterest-circled Roche Simplifies PCOS Diagnosis with New CE-Marked Blood Test
By Kathrin Folkendt Autoimmune, News, Opinion January 30, 2024 ShareTwitterFacebookPinterest-circled Autoimmune Benefits: The Next Big Thing in Workplace Health Initiatives?
By Kathrin Folkendt Endometriosis, News January 26, 2024 ShareTwitterFacebookPinterest-circled Serac Healthcare Presents Novel Imaging Approach for Endometriosis Diagnosis at SRI Annual Meeting
By Kathrin Folkendt Fertility, Medical Device, News, Reproductive Health January 26, 2024 ShareTwitterFacebookPinterest-circled Fertilis’ MicroICSI Is Set to Enhance IVF Outcomes According to New Study
By Kathrin Folkendt Ecosystem, Investor, News January 25, 2024 ShareTwitterFacebookPinterest-circled Cross-Border Impact Ventures Exceeds $90M in Final Close of Inaugural Fund Dedicated to Women’s and Children’s Health
By Kathrin Folkendt Ecosystem, News, Trend Watch January 24, 2024 ShareTwitterFacebookPinterest-circled The Femtech Word of the Year: Momentum
By Kathrin Folkendt Cycle Care, Investment, News, Sustainability January 19, 2024 ShareTwitterFacebookPinterest-circled Vyld Secures Seven-Figure Funding for Seaweed-based Women’s Health Products Using Novel Financing Model
By Kathrin Folkendt Acquisition, Cycle Care, News January 17, 2024 ShareTwitterFacebookPinterest-circled Compass Diversified Partners with The Honey Pot Company in $380M Deal to Expand Feminine Care Offerings
